Who owns Innate Pharma Adr?
- Ticker: IPHA
- CUSIP Number: 45781k204
Tip: Access positions for across all investors
Analyze quarterly positions in Innate Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Innate Pharma stock
Who bought or sold Innate Pharma Adr this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Lion Point Capital | 81k | $104k | 0% | Mar 2026 |
|
| Morgan Stanley | 44k | $56k | -6% | Mar 2026 |
|
| Jane Street | 43k | $56k | -53% | Mar 2026 |
|
| Old Mission Capital | 28k | $50k | 100% | Dec 2025 |
|
| Millennium Management | 10k | $13k | -50% | Mar 2026 |
|
| Rhumbline Advisers | 4.7k | $6.1k | -9% | Mar 2026 |
|
| UBS Group | 861.00 | $1.1k | -9% | Mar 2026 |
|
| GAMMA Investing | 240.00 | $307.008000 | -78% | Mar 2026 |
|
| Farther Finance Advisors | 10.00 | $14.000000 | 0% | Mar 2026 |
|
| Caitong International Asset Management | 2.00 | $3.000000 | 100% | Mar 2026 |
|
| Barclays | 1.00 | $2.000000 | -100% | Dec 2025 |
|
| SageView Advisory Group | 1.00 | $2.000000 | 100% | Dec 2025 |
|